Bright Minds Biosciences Inc.
DRUG
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.40% | 1,305.79% | 733.05% | 784.23% | 685.91% |
| Total Receivables | 686.70% | 697.31% | 1,486.51% | -60.23% | 36.66% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 403.23% | 342.21% | 1,119.25% | 2,371.68% | 637.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 63.64% | 1,265.81% | 738.72% | 716.09% | 681.41% |
|
|
|||||
| Total Current Assets | 63.64% | 1,265.81% | 738.72% | 716.09% | 681.41% |
| Net Property, Plant & Equipment | -45.37% | -7.69% | 975.00% | 382.06% | 236.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 63.31% | 1,241.29% | 739.17% | 714.55% | 678.28% |
|
|
|||||
| Total Accounts Payable | 302.00% | 306.99% | 242.63% | -35.18% | -57.11% |
| Total Accrued Expenses | 333.02% | 1,155.99% | 6.36% | -14.86% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.33% | 3.23% | 461.76% | 111.33% | 22.28% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 259.79% | 328.47% | 239.92% | -28.95% | -50.40% |
|
|
|||||
| Total Current Liabilities | 259.79% | 328.47% | 239.92% | -28.95% | -50.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -84.05% | 1.02% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 193.58% | 305.66% | 275.25% | -19.04% | -38.57% |
|
|
|||||
| Common Stock & APIC | 61.23% | 237.46% | 157.44% | 141.65% | 133.13% |
| Retained Earnings | -65.65% | -31.52% | -27.00% | -3.81% | 5.27% |
| Treasury Stock & Other | 124.69% | 16.80% | -4.32% | -34.34% | -32.39% |
| Total Common Equity | 62.02% | 1,337.32% | 752.76% | 823.68% | 779.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 62.02% | 1,337.32% | 752.76% | 823.68% | 779.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 62.02% | 1,337.32% | 752.76% | 823.68% | 779.78% |
|
|
|||||